Tibolone + Estradiol + Estradiol + Medroxy Progesterone Acetate

ApprovedCompleted
0 watching 0 views this week๐Ÿ”ฅ Hot
80
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
โœ“
Phase 3
5
Approved
Indication / Disease

Postmenopause

Conditions

Postmenopause, Osteoporosis

Trial Timeline

Feb 1, 2003 โ†’ Mar 1, 2005

About Tibolone + Estradiol + Estradiol + Medroxy Progesterone Acetate

Tibolone + Estradiol + Estradiol + Medroxy Progesterone Acetate is a approved stage product being developed by Organon for Postmenopause. The current trial status is completed. This product is registered under clinical trial identifier NCT00294463. Target conditions include Postmenopause, Osteoporosis.

Hype Score Breakdown

Clinical
30
Activity
20
Company
5
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT00294463ApprovedCompleted